Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China · Delayed Price · Currency is CNY 60.05
-0.66 (-1.09%)
Sep 12, 2025, 3:00 PM CST
SHA:603392 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,690 | 2,215 | 5,493 | 11,167 | 5,702 | 2,337 | Upgrade |
Other Revenue | 32.65 | 30.31 | 17.3 | 18.52 | 48.34 | 17.14 | Upgrade |
| 1,723 | 2,245 | 5,511 | 11,185 | 5,750 | 2,354 | Upgrade | |
Revenue Growth (YoY) | -36.50% | -59.25% | -50.73% | 94.51% | 144.25% | 98.88% | Upgrade |
Cost of Revenue | 788.37 | 866.34 | 1,084 | 1,198 | 850.67 | 473.6 | Upgrade |
Gross Profit | 934.55 | 1,379 | 4,427 | 9,987 | 4,900 | 1,881 | Upgrade |
Selling, General & Admin | 775.44 | 790.16 | 1,878 | 3,490 | 1,874 | 810.21 | Upgrade |
Research & Development | 679.02 | 874.57 | 1,177 | 1,091 | 677.42 | 309.13 | Upgrade |
Other Operating Expenses | 181.08 | 14.67 | 31.57 | 51.28 | 26.71 | 12.51 | Upgrade |
Operating Expenses | 1,679 | 1,694 | 3,063 | 4,723 | 2,662 | 1,156 | Upgrade |
Operating Income | -744.17 | -315.37 | 1,364 | 5,265 | 2,238 | 724.74 | Upgrade |
Interest Expense | -18.72 | -8.32 | -6.86 | -7.67 | -5.69 | -1.69 | Upgrade |
Interest & Investment Income | 132.88 | 169.09 | 186.88 | 78.26 | 21 | 18.58 | Upgrade |
Currency Exchange Gain (Loss) | 6.1 | 7.42 | 13.01 | 27.89 | -8.75 | -14.29 | Upgrade |
Other Non Operating Income (Expenses) | 11.92 | -5.77 | -1.87 | -1 | 0.05 | -0.79 | Upgrade |
EBT Excluding Unusual Items | -612 | -152.95 | 1,555 | 5,362 | 2,244 | 726.55 | Upgrade |
Gain (Loss) on Sale of Investments | 45.74 | 36.71 | 24.66 | 9.98 | 0.03 | 0.35 | Upgrade |
Gain (Loss) on Sale of Assets | 6.14 | 7.39 | -1.08 | -2.74 | -0.97 | 0.42 | Upgrade |
Asset Writedown | - | - | -259.15 | - | - | - | Upgrade |
Other Unusual Items | 223.76 | 176.33 | 73.7 | 213.42 | 80.85 | 37.13 | Upgrade |
Pretax Income | -336.35 | 67.48 | 1,393 | 5,583 | 2,324 | 764.45 | Upgrade |
Income Tax Expense | -36.36 | -41.61 | 146.89 | 719.39 | 244.93 | 82.64 | Upgrade |
Earnings From Continuing Operations | -299.99 | 109.09 | 1,247 | 4,863 | 2,079 | 681.82 | Upgrade |
Minority Interest in Earnings | 1.71 | -2.86 | 1.18 | -127.51 | -57.75 | -4.82 | Upgrade |
Net Income | -298.28 | 106.24 | 1,248 | 4,736 | 2,021 | 677 | Upgrade |
Net Income to Common | -298.28 | 106.24 | 1,248 | 4,736 | 2,021 | 677 | Upgrade |
Net Income Growth | - | -91.48% | -73.65% | 134.28% | 198.59% | 224.13% | Upgrade |
Shares Outstanding (Basic) | 1,362 | 1,328 | 1,260 | 1,250 | 1,230 | 1,195 | Upgrade |
Shares Outstanding (Diluted) | 1,362 | 1,328 | 1,260 | 1,250 | 1,230 | 1,195 | Upgrade |
Shares Change (YoY) | 9.41% | 5.37% | 0.86% | 1.55% | 2.96% | 8.71% | Upgrade |
EPS (Basic) | -0.22 | 0.08 | 0.99 | 3.79 | 1.64 | 0.57 | Upgrade |
EPS (Diluted) | -0.22 | 0.08 | 0.99 | 3.79 | 1.64 | 0.57 | Upgrade |
EPS Growth | - | -91.92% | -73.88% | 130.69% | 190.01% | 198.16% | Upgrade |
Free Cash Flow | -702.83 | -532.27 | 378.15 | 3,203 | 634.16 | 77.77 | Upgrade |
Free Cash Flow Per Share | -0.52 | -0.40 | 0.30 | 2.56 | 0.52 | 0.07 | Upgrade |
Dividend Per Share | - | - | 0.320 | 0.714 | 0.099 | 0.088 | Upgrade |
Dividend Growth | - | - | -55.20% | 624.44% | 12.04% | - | Upgrade |
Gross Margin | 54.24% | 61.42% | 80.34% | 89.29% | 85.21% | 79.88% | Upgrade |
Operating Margin | -43.19% | -14.04% | 24.75% | 47.07% | 38.91% | 30.78% | Upgrade |
Profit Margin | -17.31% | 4.73% | 22.64% | 42.34% | 35.15% | 28.76% | Upgrade |
Free Cash Flow Margin | -40.79% | -23.71% | 6.86% | 28.63% | 11.03% | 3.30% | Upgrade |
EBITDA | -484.73 | -65.06 | 1,579 | 5,401 | 2,334 | 809.21 | Upgrade |
EBITDA Margin | -28.13% | -2.90% | 28.66% | 48.28% | 40.59% | 34.37% | Upgrade |
D&A For EBITDA | 259.44 | 250.31 | 215.29 | 136.17 | 96.2 | 84.47 | Upgrade |
EBIT | -744.17 | -315.37 | 1,364 | 5,265 | 2,238 | 724.74 | Upgrade |
EBIT Margin | -43.19% | -14.04% | 24.75% | 47.07% | 38.91% | 30.78% | Upgrade |
Effective Tax Rate | - | - | 10.54% | 12.89% | 10.54% | 10.81% | Upgrade |
Revenue as Reported | 1,723 | 2,245 | 5,511 | 11,185 | 5,750 | 2,354 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.